中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2015年
2期
26-26,27
,共2页
替吉奥%胃癌%生活质量
替吉奧%胃癌%生活質量
체길오%위암%생활질량
Egafur%Gastric cancer%The quality of life
目的:探讨以替吉奥(S-1)为基础化疗对晚期胃癌患者生活质量的影响。方法选取我院93例晚期胃癌患者作为研究对象。按随机数字表将患者分为A组、B组及C组,每组各31例。A组采用S-1治疗。B组采用S-1联合TXT(多西他塞)。C组采用S-1联合L-OHP(奥沙利铂)。对比3组临床疗效及生活质量。结果①A组有效率35.48%,B组有效率45.16%,C组54.84%;两两比较,P>0.05差异无统计学意义。②此外,三组生活质量评分比较,P>0.05,差异无统计学意义。结论应用S-1单药、S-1联合TXT、S-1联合L-OHP治疗晚期胃癌,临床疗效相当,不良反应均可耐受,且可显著改善患者生活质量。
目的:探討以替吉奧(S-1)為基礎化療對晚期胃癌患者生活質量的影響。方法選取我院93例晚期胃癌患者作為研究對象。按隨機數字錶將患者分為A組、B組及C組,每組各31例。A組採用S-1治療。B組採用S-1聯閤TXT(多西他塞)。C組採用S-1聯閤L-OHP(奧沙利鉑)。對比3組臨床療效及生活質量。結果①A組有效率35.48%,B組有效率45.16%,C組54.84%;兩兩比較,P>0.05差異無統計學意義。②此外,三組生活質量評分比較,P>0.05,差異無統計學意義。結論應用S-1單藥、S-1聯閤TXT、S-1聯閤L-OHP治療晚期胃癌,臨床療效相噹,不良反應均可耐受,且可顯著改善患者生活質量。
목적:탐토이체길오(S-1)위기출화료대만기위암환자생활질량적영향。방법선취아원93례만기위암환자작위연구대상。안수궤수자표장환자분위A조、B조급C조,매조각31례。A조채용S-1치료。B조채용S-1연합TXT(다서타새)。C조채용S-1연합L-OHP(오사리박)。대비3조림상료효급생활질량。결과①A조유효솔35.48%,B조유효솔45.16%,C조54.84%;량량비교,P>0.05차이무통계학의의。②차외,삼조생활질량평분비교,P>0.05,차이무통계학의의。결론응용S-1단약、S-1연합TXT、S-1연합L-OHP치료만기위암,림상료효상당,불량반응균가내수,차가현저개선환자생활질량。
Objective To explore the S-1 chemotherapy on the quality of life of patients with advanced gastric cancer. Methods Select 93 cases of patients with advanced gastric cancer as the research object. According to random number table will be divided into group A and group B and C group, each group of 31 cases. A group was treated by S-1. Group B using S-1 joint TXT. Group C using S-1 joint L-OHP. Compared three groups of clinical curative effect and quality of life. Results ①A set of effective rate was 35.48%, B group effectiveness 45.16%, group C effective rate was 54.84%. comparison between any two, there was no statistically signiifcant difference(P>0.05).②In addition, three sets of quality of life score comparison, P>0.05, there was no statistically signiifcant difference. Conclusion Application S-1 single drug, S-1 joint TXT, S-1 joint L-OHP treatment of advanced gastric cancer, clinical efifcacy, adverse reactions can be tolerated, and can signiifcantly improve patients' quality of life.